3rd. Circ. Reverses GSK Win In Avandia Marketing Suit

By Mike LaSusa (December 17, 2019, 10:32 PM EST) -- The Third Circuit ruled in a precedential opinion Tuesday that a Pennsylvania federal judge erred on several grounds in granting summary judgment to GlaxoSmithKline in a lawsuit over the marketing of the diabetes drug Avandia....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!